Pancreas

Published by: Lippincott Williams & Wilkins  

People

  1. Raj
    Raj
  2. Reidy
    Reidy
  3. Capanu
    Capanu
  4. Chou
    Chou
  5. Tang
    Tang
  6. Bodei
    Bodei
  7. Do
    Do
  8. Untch
    Untch
  9. Basturk
    Basturk
  10. Krebs
    Krebs

Groups

  1. Department of Medicine (27)
  2. Gastrointestinal Oncology Service (27)
  3. Solid Tumor Oncology Division (27)
  4. Center for Pancreatic Cancer Research (25)
  5. Biostatistics Service (9)
  6. Epidemiology and Biostatistics (9)
  7. Radiology, Department of (6)
  8. Survivorship Research (6)
  9. Sloan Kettering Institute Postdocs (5)
  10. Surgery (5)
Search Within
  1. "Solid Tumor Oncology Division"
  2. "Nitya Raj"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (5)
  3. Correspondence (1)
Groups
  1. Department of Medicine (27)
  2. Gastrointestinal Oncology Service (27)
  3. Solid Tumor Oncology Division (27)
  4. Center for Pancreatic Cancer Research (25)
  5. Biostatistics Service (9)
  6. Epidemiology and Biostatistics (9)

More Groups

People
  1. Nitya Raj (27)
  2. Diane Reidy (25)
  3. Marinela Capanu (9)
  4. David Klimstra (6)
  5. Joanne Chou (6)
  6. Tiffany Le (6)

More People

Years
  1. 2022 (8)
  2. 2021 (3)
  3. 2020 (3)
  4. 2019 (1)
  5. 2018 (4)
  6. 2017 (4)

More Years

Publishers
  1. Lippincott Williams & Wilkins (27)

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early onset well-differentiated pancreatic neuroendocrine tumors: clinical presentation, pathologic features, and oncological outcomes
    Meeting Abstract

    Pulvirenti, A.; Hauser, H.; Le, T.; McIntyre, C.; Reidy-Lagunes, D.; Wei, A.; Raj, N.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Safety, pharmacodynamic, and antitumor activity of tidutamab, an SSTR2 x CD3 bispecific antibody, in subjects with advanced neuroendocrine tumors
    Meeting Abstract

    El-Rayes, B. F.; Hendifar, A. E.; Pant, S.; Wilky, B. A.; Reilley, M. J.; Benson, A. B.; Chow, W. A.; Konda, B.; Starr, J.; Ahn, D. H.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab-based therapy in previously treated extrapulmonary poorly-differentiated neuroendocrine carcinomas: Results of part B (pembrolizumab plus chemotherapy)
    Meeting Abstract

    Chan, J. A.; Raj, N. P.; Aggarwal, R. R.; Hope, T. A.; Kolli, K. P.; Zhang, L.; Fattah, D.; Calabrese, S.; Grabowsky, J. A.; Perez, K.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood-based genomic assessment of clinical efficacy and toxicity of (177)Lu-DOTATATE of neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, K. G.; Krebs, S.; Reidy-Lagunes, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schòˆder, H.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of neuroendocrine neoplasms (NENs) treated with immune checkpoint inhibitors (ICIs): A single institution experience
    Meeting Abstract

    Hauser, H.; Le, T.; Chou, J. F.; Heffernan, O.; DeMore, A.; Gonen, S.; Capanu, M.; Reidy-Lagunes, D.; Raj, N.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)
    Meeting Abstract

    Raj, N.; Cruz, E.; Chou, J.; Capanu, M.; DeMore, A.; Hauser, H.; Heffernan, O.; Le, T.; Saltz, L.; Reidy-Lagunes, D.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Urinary neuroendocrine neoplasms (NENs) treated in the "modern era": A multicenter retrospective review
    Meeting Abstract

    Le, B. K.; McGarrah, P. W.; Whitman, J.; Paciorek, A.; Raj, N.; Reidy-Lagunes, D.; Hauser, H.; Le, T.; Del Rivero, J.; Apolo, A.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Preliminary safety, PK/PD, and antitumor activity of XmAb18087, an SSTR2 x CD3 bispecific antibody, in patients with advanced neuroendocrine tumors
    Meeting Abstract

    El-Rayes, B.; Pant, S.; Villalobos, V.; Hendifar, A.; Chow, W.; Konda, B.; Reilley, M.; Benson, A.; Fisher, G.; Starr, J.; more...
    Pancreas (2021)

    Fulltext@MSK | Save
  • Urinary neuroendocrine neoplasms treated in the "modern era": A multicenter retrospective review
    Meeting Abstract

    Le, B.; McGarrah, P.; Whitman, J.; Paciorek, A.; Raj, N.; Reidy-Lagunes, D.; Hauser, H.; Le, T.; Del Rivero, J.; Apolo, A.; more...
    Pancreas (2021)

    Fulltext@MSK | Save

    • Pancreas – authorized name for:

    Name ISSN / ISBN Publisher
    Pancreas 08853177 Lippincott Williams & Wilkins
    Pancreas 0885-3177 Unknown
    Pancreas 08853177 Unknown
    Pancreas 0885-3177 Lippincott Williams & Wilkins
    Pancreas 0885-3177 Lippincott Williams & Wilkins
    Pancreas 0885-3177 Lippincott-Raven
    Pancreas 08853177 Wolters Kluwer Health, Inc
    Pancreas 15364828 Unknown
    Pancreas 15364828 Lippincott Williams & Wilkins
    Pancreas 08853177 Lippincott Williams & Wilkins
    Pancreas 08853177 Lippincott Williams & Wilkins
    Pancreas 15364828 Wolters Kluwer Health, Inc